scispace - formally typeset
Search or ask a question
Author

Amos Kirilovsky

Bio: Amos Kirilovsky is an academic researcher from Pierre-and-Marie-Curie University. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 14, co-authored 20 publications receiving 16344 citations. Previous affiliations of Amos Kirilovsky include Paris Descartes University & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI
29 Sep 2006-Science
TL;DR: In situ analysis of tumor-infiltrating immune cells may be a valuable prognostic tool in the treatment of colorectal cancer and possibly other malignancies.
Abstract: The role of the adaptive immune response in controlling the growth and recurrence of human tumors has been controversial. We characterized the tumor-infiltrating immune cells in large cohorts of human colorectal cancers by gene expression profiling and in situ immunohistochemical staining. Collectively, the immunological data (the type, density, and location of immune cells within the tumor samples) were found to be a better predictor of patient survival than the histopathological methods currently used to stage colorectal cancer. The results were validated in two additional patient populations. These data support the hypothesis that the adaptive immune response influences the behavior of human tumors. In situ analysis of tumor-infiltrating immune cells may therefore be a valuable prognostic tool in the treatment of colorectal cancer and possibly other malignancies.

5,536 citations

Journal ArticleDOI
TL;DR: ClueGO is an easy to use Cytoscape plug-in that strongly improves biological interpretation of large lists of genes and creates a functionally organized GO/pathway term network.
Abstract: We have developed ClueGO, an easy to use Cytoscape plug-in that strongly improves biological interpretation of large lists of genes. ClueGO integrates Gene Ontology (GO) terms as well as KEGG/BioCarta pathways and creates a functionally organized GO/pathway term network. It can analyze one or compare two lists of genes and comprehensively visualizes functionally grouped terms. A one-click update option allows ClueGO to automatically download the most recent GO/KEGG release at any time. ClueGO provides an intuitive representation of the analysis results and can be optionally used in conjunction with the GOlorize plug-in.

4,768 citations

Journal ArticleDOI
TL;DR: Signs of an immune response within colorectal cancers are associated with the absence of pathological evidence of early metastatic invasion and with prolonged survival.
Abstract: Background The role of tumor-infiltrating immune cells in the early metastatic invasion of colorectal cancer is unknown. Methods We studied pathological signs of early metastatic invasion (venous emboli and lymphatic and perineural invasion) in 959 specimens of resected colorectal cancer. The local immune response within the tumor was studied by flow cytometry (39 tumors), low-density-array real-time polymerase-chain-reaction assay (75 tumors), and tissue microarrays (415 tumors). Results Univariate analysis showed significant differences in disease-free and overall survival according to the presence or absence of histologic signs of early metastatic invasion (P<0.001). Multivariate Cox analysis showed that an early conventional pathological tumor–node–metastasis stage (P<0.001) and the absence of early metastatic invasion (P=0.04) were independently associated with increased survival. As compared with tumors with signs of early metastatic invasion, tumors without such signs had increased infiltrates of i...

1,956 citations

Journal ArticleDOI
Franck Pagès, Bernhard Mlecnik, Florence Marliot, Gabriela Bindea1, Gabriela Bindea2, Gabriela Bindea3, Fang Shu Ou4, Carlo Bifulco5, Alessandro Lugli6, Inti Zlobec6, Tilman T. Rau6, Martin D. Berger7, Iris D. Nagtegaal8, Elisa Vink-Börger8, Arndt Hartmann9, Carol Geppert9, Julie Kolwelter9, Susanne Merkel, Robert Grützmann, Marc Van den Eynde10, Anne Jouret-Mourin10, Alex Kartheuser10, Daniel Léonard10, Christophe Remue10, Julia Y. Wang11, Julia Y. Wang12, Prashant Bavi12, Michael H.A. Roehrl13, Michael H.A. Roehrl12, Michael H.A. Roehrl11, Pamela S. Ohashi11, Linh T. Nguyen11, Seong Jun Han11, Heather L. MacGregor11, Sara Hafezi-Bakhtiari11, Bradly G. Wouters11, Giuseppe Masucci14, Emilia Andersson14, Eva Zavadova15, Michal Vocka15, Jan Spacek15, Lubos Petruzelka15, Bohuslav Konopasek15, Pavel Dundr15, Helena Skalova15, Kristyna Nemejcova15, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi16, Fabio Grizzi16, Tessa Fredriksen3, Tessa Fredriksen2, Tessa Fredriksen1, Bénédicte Buttard3, Bénédicte Buttard1, Bénédicte Buttard2, Mihaela Angelova1, Mihaela Angelova3, Mihaela Angelova2, Angela Vasaturo1, Angela Vasaturo3, Angela Vasaturo2, Pauline Maby2, Pauline Maby1, Pauline Maby3, Sarah E. Church, Helen K. Angell, Lucie Lafontaine3, Lucie Lafontaine1, Lucie Lafontaine2, Daniela Bruni1, Daniela Bruni2, Daniela Bruni3, Carine El Sissy, Nacilla Haicheur, Amos Kirilovsky, Anne Berger, Christine Lagorce, Jeffrey P. Meyers4, Christopher Paustian5, Zipei Feng5, Carmen Ballesteros-Merino5, Jeroen R. Dijkstra8, Carlijn van de Water8, Shannon van Vliet8, Nikki Knijn8, Ana Maria Mușină, Dragos Viorel Scripcariu, Boryana Popivanova17, Mingli Xu17, Tomonobu Fujita17, Shoichi Hazama18, Nobuaki Suzuki18, Hiroaki Nagano18, Kiyotaka Okuno19, Toshihiko Torigoe20, Noriyuki Sato20, Tomohisa Furuhata20, Ichiro Takemasa20, Kyogo Itoh21, P. Patel, Hemangini H. Vora, Birva Shah, Jayendrakumar B. Patel, Kruti N. Rajvik, Shashank J. Pandya, Shilin N. Shukla, Yili Wang22, Guanjun Zhang22, Yutaka Kawakami17, Francesco M. Marincola23, Paolo A. Ascierto, Daniel J. Sargent4, Bernard A. Fox5, Bernard A. Fox24, Jérôme Galon3, Jérôme Galon2, Jérôme Galon1 
TL;DR: The immunoscore provides a reliable estimate of the risk of recurrence in patients with colon cancer and supports the implementation of the consensus Immunoscore as a new component of a TNM-Immune classification of cancer.

1,326 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: An R package, clusterProfiler that automates the process of biological-term classification and the enrichment analysis of gene clusters and can be easily extended to other species and ontologies is presented.
Abstract: Increasing quantitative data generated from transcriptomics and proteomics require integrative strategies for analysis Here, we present an R package, clusterProfiler that automates the process of biological-term classification and the enrichment analysis of gene clusters The analysis module and visualization module were combined into a reusable workflow Currently, clusterProfiler supports three species, including humans, mice, and yeast Methods provided in this package can be easily extended to other species and ontologies The clusterProfiler package is released under Artistic-20 License within Bioconductor project The source code and vignette are freely available at http://bioconductororg/packages/release/bioc/html/clusterProfilerhtml

16,644 citations

Journal ArticleDOI
19 Mar 2010-Cell
TL;DR: The principal mechanisms that govern the effects of inflammation and immunity on tumor development are outlined and attractive new targets for cancer therapy and prevention are discussed.

8,664 citations

Journal ArticleDOI
TL;DR: This study showed that mismatch-repair status predicted clinical benefit of immune checkpoint blockade with pembrolizumab, and high somatic mutation loads were associated with prolonged progression-free survival.
Abstract: BackgroundSomatic mutations have the potential to encode “non-self” immunogenic antigens. We hypothesized that tumors with a large number of somatic mutations due to mismatch-repair defects may be susceptible to immune checkpoint blockade. MethodsWe conducted a phase 2 study to evaluate the clinical activity of pembrolizumab, an anti–programmed death 1 immune checkpoint inhibitor, in 41 patients with progressive metastatic carcinoma with or without mismatch-repair deficiency. Pembrolizumab was administered intravenously at a dose of 10 mg per kilogram of body weight every 14 days in patients with mismatch repair–deficient colorectal cancers, patients with mismatch repair–proficient colorectal cancers, and patients with mismatch repair–deficient cancers that were not colorectal. The coprimary end points were the immune-related objective response rate and the 20-week immune-related progression-free survival rate. ResultsThe immune-related objective response rate and immune-related progression-free survival ...

6,835 citations

Journal ArticleDOI
TL;DR: In the latest version 10.5 of STRING, the biggest changes are concerned with data dissemination: the web frontend has been completely redesigned to reduce dependency on outdated browser technologies, and the database can now also be queried from inside the popular Cytoscape software framework.
Abstract: A system-wide understanding of cellular function requires knowledge of all functional interactions between the expressed proteins. The STRING database aims to collect and integrate this information, by consolidating known and predicted protein-protein association data for a large number of organisms. The associations in STRING include direct (physical) interactions, as well as indirect (functional) interactions, as long as both are specific and biologically meaningful. Apart from collecting and reassessing available experimental data on protein-protein interactions, and importing known pathways and protein complexes from curated databases, interaction predictions are derived from the following sources: (i) systematic co-expression analysis, (ii) detection of shared selective signals across genomes, (iii) automated text-mining of the scientific literature and (iv) computational transfer of interaction knowledge between organisms based on gene orthology. In the latest version 10.5 of STRING, the biggest changes are concerned with data dissemination: the web frontend has been completely redesigned to reduce dependency on outdated browser technologies, and the database can now also be queried from inside the popular Cytoscape software framework. Further improvements include automated background analysis of user inputs for functional enrichments, and streamlined download options. The STRING resource is available online, at http://string-db.org/.

5,569 citations

Journal ArticleDOI
29 Sep 2006-Science
TL;DR: In situ analysis of tumor-infiltrating immune cells may be a valuable prognostic tool in the treatment of colorectal cancer and possibly other malignancies.
Abstract: The role of the adaptive immune response in controlling the growth and recurrence of human tumors has been controversial. We characterized the tumor-infiltrating immune cells in large cohorts of human colorectal cancers by gene expression profiling and in situ immunohistochemical staining. Collectively, the immunological data (the type, density, and location of immune cells within the tumor samples) were found to be a better predictor of patient survival than the histopathological methods currently used to stage colorectal cancer. The results were validated in two additional patient populations. These data support the hypothesis that the adaptive immune response influences the behavior of human tumors. In situ analysis of tumor-infiltrating immune cells may therefore be a valuable prognostic tool in the treatment of colorectal cancer and possibly other malignancies.

5,536 citations